Sanhuang Xiexin decoction promotes good functional outcome in acute ischemic stroke.

Juexian SongXin ChenYi LyuWei ZhuangJing ZhangLi GaoXiao-Lin Tong

Published in: Brain and behavior (2018)

The prescription of Sanhuang Xiexin is efficient and safe in the treatment of AIS patients after endovascular intervention examination through reducing the inflammatory factors.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
chronic kidney disease
oxidative stress
peritoneal dialysis
patient reported outcomes